| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584416 | Experimental and Molecular Pathology | 2017 | 26 Pages |
Abstract
HBXIP over-expression appears to associate with cervical cancer progression, and may potentially be used as a cervical cancer biomarker for the early diagnosis, prognostic evaluation and therapeutic target for cervical cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Nan Li, Yixuan Wang, Shuanlong Che, Yang Yang, Junjie Piao, Shuangping Liu, Zhenhua Lin,